Navigation Links
DaVita Hosts National Quality Week 2009
Date:7/28/2009

DENVER, July 28 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today held its formal kickoff for a week-long conference hosted by DaVita's Office of the Chief Medical Officer (OCMO) titled National Quality Week 2009. DaVita(R) clinicians, dietitians, Physician Council Members, members of The Office of the Chief Medical Officer and other practitioners began gathering Monday to review DaVita's current clinical programs and plan new initiatives to improve patients' clinical outcomes for 2010 and beyond.

(Logo:http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

The week-long annual event will allow DaVita to re-prioritize current projects according to clinical-team feedback, and updates from the medical staff. This mid-year meeting generates program adjustments aimed at continually improving patient outcomes. The regular and rigorous review of data and refinement of programs has helped DaVita achieve the best clinical outcomes in the kidney care industry. National Quality Week is yet another reason why DaVita is recognized as a leading provider of kidney care in the United States.

"National Quality Week will allow our team to focus on our innovative clinical initiatives and processes in a way that will facilitate improvement in programs on behalf of patient outcomes," said Allen R. Nissenson, M.D., Chief Medical Officer for DaVita.

Each meeting during National Quality Week will focus on programs such as IMPACT(TM) (Incident Management of Patients, Actions Centered on Treatment), CathAway (a comprehensive catheter reduction initiative), Infection Control, Integration of Quality Systems, and Patient Safety.

DaVita and IMPACT are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita has been recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Workplaces(TM). As of March 31, 2009, DaVita operated or provided administrative services at 1,475 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 114,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Donates Toys, Shoes and School Supplies for Army National Guard to Distribute in Iraq
2. Mayor Julian Jolly Reseueollo Dialysis Center Officially Opens Doors With Support From Bridge of Life - DaVita Medical Missions
3. Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence
4. DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
5. DaVitas Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland
6. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
7. DaVita.com Provides Easy Recipes to Plan Your Fathers Day Dinner
8. DaVita Launches First Corporate Social Responsibility Report With Nationwide Community Service Blitz
9. DaVita Named One of Best Companies to Work for in Colorado
10. DaVita Named to List of Best Places to Work in Los Angeles by the Los Angeles Business Journal
11. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... CO (PRWEB) , ... September 21, 2017 , ... ... Interview of the Month, Lewis and Clark College Emeritus Professor of Education Gregory ... Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... On ... Best Places to Work in the Research Triangle for 2017. , Winners were ... company had to meet a threshold in employee participation--a percentage that varies based ...
(Date:9/20/2017)... ... September 20, 2017 , ... Mirror Mirror Beauty ... , Look Awesome This Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, the ... , Mirror Mirror Beauty Boutique is Houston’s largest CoolSculpting provider, holding ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud ... The Guard®, has helped another long-time client pass their Department of Health and ... the law. , Thanks to the help of the Compliancy Group's Audit Response ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Five consumer ... innovation and market impact in 27 different categories. Nopavera Plus was named ... category will be announced at SupplySide West 2017 during presentations at SupplySide Central on ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
(Date:9/6/2017)... , Sept. 6, 2017  Robert G. Szewc, ... Pinnacle Professional Member in recognition of his contributions to ... serves as a Nephrologist at the practice of Kidney ... medicine, kidney care and hypertension solutions. He has worked ... years of career experience, as well as expertise in ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: